Cat.#: ACPP-1350
| Despition | Presenilin 2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
| ACPP-1760 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1760) | 100 µg | inquiry |
| ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
| ACPP-1789 | Human PEDF Protein (AC1789) | 5 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1792 | Rat CALB1 Protein (AC1792) | 1 µg | inquiry |
| ACPP-1374 | Human Ephrin A4 Protein (AC1374) | 2 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.